Cytosorbents Property Plant Equipment vs Retained Earnings Analysis
CTSO Stock | USD 0.98 0.01 1.03% |
Cytosorbents Crp financial indicator trend analysis is way more than just evaluating Cytosorbents Crp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cytosorbents Crp is a good investment. Please check the relationship between Cytosorbents Crp Property Plant Equipment and its Retained Earnings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
Property Plant Equipment vs Retained Earnings
Property Plant Equipment vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cytosorbents Crp Property Plant Equipment account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.
The correlation between Cytosorbents Crp's Property Plant Equipment and Retained Earnings is -0.78. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Cytosorbents Crp, assuming nothing else is changed. The correlation between historical values of Cytosorbents Crp's Property Plant Equipment and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Cytosorbents Crp are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Property Plant Equipment i.e., Cytosorbents Crp's Property Plant Equipment and Retained Earnings go up and down completely randomly.
Correlation Coefficient | -0.78 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Property Plant Equipment
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Cytosorbents Crp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cytosorbents Crp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.At this time, Cytosorbents Crp's Selling General Administrative is very stable compared to the past year. As of the 21st of May 2024, Issuance Of Capital Stock is likely to grow to about 17.5 M, while Tax Provision is likely to drop (854.4 K).
2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 62.9M | 60.9M | 66.9M | 70.2M | Total Revenue | 40.1M | 29.4M | 36.3M | 38.2M |
Cytosorbents Crp fundamental ratios Correlations
Click cells to compare fundamentals
Cytosorbents Crp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cytosorbents Crp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 27.4M | 90.0M | 89.5M | 63.2M | 53.3M | 55.9M | |
Short Long Term Debt Total | 16.1M | 1.0M | 13.8M | 18.3M | 18.3M | 19.2M | |
Total Current Liabilities | 9.9M | 10.2M | 13.7M | 9.7M | 14.5M | 15.3M | |
Net Debt | 3.9M | (70.4M) | (38.3M) | (3.9M) | 4.2M | 4.4M | |
Retained Earnings | (188.8M) | (196.6M) | (221.2M) | (254.0M) | (282.5M) | (268.4M) | |
Cash | 12.2M | 71.4M | 52.1M | 22.1M | 14.1M | 13.2M | |
Common Stock Total Equity | 32.6K | 43.2K | 43.5K | 43.6K | 39.3K | 51.6K | |
Common Stock Shares Outstanding | 32.3M | 38.8M | 43.4M | 43.6M | 44.7M | 46.9M | |
Liabilities And Stockholders Equity | 27.4M | 90.0M | 89.5M | 63.2M | 53.3M | 55.9M | |
Total Liab | 24.0M | 10.7M | 26.9M | 27.9M | 30.0M | 31.5M | |
Property Plant And Equipment Gross | 3.0M | 3.1M | 18.6M | 23.3M | 25.2M | 26.4M | |
Total Current Assets | 20.9M | 82.5M | 64.3M | 33.8M | 25.7M | 17.6M | |
Accumulated Other Comprehensive Income | 526.0K | (1.7M) | 525.6K | 2.3M | 529.3K | 555.8K | |
Other Current Liab | 5.6M | 6.8M | 8.2M | 6.3M | 6.5M | 6.8M | |
Total Stockholder Equity | 3.4M | 79.2M | 62.6M | 35.4M | 23.3M | 12.9M | |
Property Plant And Equipment Net | 3.0M | 3.1M | 18.6M | 23.3M | 22.1M | 23.2M | |
Non Current Assets Total | 6.5M | 7.5M | 25.2M | 29.5M | 27.6M | 28.9M | |
Cash And Short Term Investments | 12.2M | 71.4M | 52.1M | 22.1M | 14.1M | 14.1M | |
Non Current Liabilities Total | 14.0M | 582K | 13.3M | 18.1M | 15.4M | 16.2M | |
Other Stockholder Equity | 191.6M | 277.5M | 283.2M | 287.0M | 305.2M | 160.4M | |
Common Stock | 32.6K | 43.2K | 43.5K | 43.6K | 54.2K | 53.5K | |
Accounts Payable | 2.0M | 1.8M | 2.8M | 1.7M | 3.8M | 4.0M | |
Non Currrent Assets Other | 3.5M | 4.3M | 1.9M | 1.7M | (3.7M) | (3.5M) | |
Other Current Assets | 2.1M | 3.2M | 2.9M | 2.5M | 1.8M | 1.1M | |
Good Will | 1.8M | 2.6M | 3.4M | 4.2M | 4.9M | 5.1M | |
Intangible Assets | 3.4M | 4.2M | 4.7M | 4.4M | 3.9M | 4.1M | |
Other Assets | 123.5K | 5.4M | 6.6M | 1.7M | 2.0M | 1.1M | |
Property Plant Equipment | 3.0M | 2.1M | 18.6M | 10.7M | 12.4M | 13.0M | |
Long Term Debt | 6.0M | 9.3M | 13.4M | 5M | 2.5M | 3.8M | |
Net Receivables | 4.5M | 5.2M | 4.5M | 5.7M | 6.1M | 6.4M | |
Retained Earnings Total Equity | (188.8M) | (196.6M) | (221.2M) | (254.0M) | (228.6M) | (217.2M) | |
Inventory | 2.1M | 2.7M | 4.8M | 3.5M | 3.7M | 1.9M | |
Short Term Debt | 2.1M | 447K | 571K | 109K | 2.9M | 3.0M | |
Net Tangible Assets | 56.6K | 79.2M | 62.6M | 35.4M | 40.7M | 23.3M | |
Capital Surpluse | 191.6M | 277.5M | 283.2M | 287.0M | 330.1M | 215.6M | |
Short Long Term Debt | 4M | 666.7K | 1.7M | 2.5M | 2.9M | 1.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Cytosorbents Stock analysis
When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 0.814 | Quarterly Revenue Growth (0.08) | Return On Assets (0.32) | Return On Equity (0.97) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.